CHEBI:139030 - hydroxysafflor yellow A

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name hydroxysafflor yellow A
ChEBI ID CHEBI:139030
Definition A C-glycosyl compound that is 3,4,5-trihydroxycyclohexa-2,5-dien-1-one which is substituted by β-D-glucosyl groups at positions 2 and 4, and by a p-hydroxycinnamoyl group at position 6. It is the main bioactive compound of a traditional Chinese medicine obtained from safflower (Carthamus tinctorius).
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Sabrina Toro
Supplier Information
Download Molfile XML SDF
more structures >>
Formula C27H32O16
Net Charge 0
Average Mass 612.534
Monoisotopic Mass 612.16903
InChI InChI=1S/C27H32O16/c28-7-12-16(32)19(35)21(37)23(42-12)15-18(34)14(11(31)6-3-9-1-4-10(30)5-2-9)24(39)27(41,25(15)40)26-22(38)20(36)17(33)13(8-29)43-26/h1-6,12-13,16-17,19-23,26,28-30,32-33,35-41H,7-8H2/b6-3+/t12-,13-,16-,17-,19+,20+,21-,22-,23+,26-,27?/m1/s1
InChIKey LIPJRCGLQNIXGO-ONZBGLOFSA-N
SMILES O1[C@H]([C@H](O)[C@@H](O)[C@H](O)[C@H]1CO)C2=C(O)C(C(O)=C(C2=O)C(=O)/C=C/C3=CC=C(O)C=C3)(O)[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)CO
Metabolite of Species Details
Carthamus tinctorius (NCBI:txid4222) Found in flower (BTO:0000469). See: PubMed
Roles Classification
Chemical Role(s): antioxidant
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
radical scavenger
A role played by a substance that can react readily with, and thereby eliminate, radicals.
Biological Role(s): EC 3.2.1.48 (sucrose alpha-glucosidase) inhibitor
An EC 3.2.1.* (glycosidase) inhibitor that interferes with the action of sucrose alpha-glucosidase (EC 3.2.1.48).
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
Application(s): anti-inflammatory agent
Any compound that has anti-inflammatory effects.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing hydroxysafflor yellow A (CHEBI:139030) has role anti-inflammatory agent (CHEBI:67079)
hydroxysafflor yellow A (CHEBI:139030) has role antineoplastic agent (CHEBI:35610)
hydroxysafflor yellow A (CHEBI:139030) has role antioxidant (CHEBI:22586)
hydroxysafflor yellow A (CHEBI:139030) has role EC 3.2.1.48 (sucrose α-glucosidase) inhibitor (CHEBI:67231)
hydroxysafflor yellow A (CHEBI:139030) has role neuroprotective agent (CHEBI:63726)
hydroxysafflor yellow A (CHEBI:139030) has role plant metabolite (CHEBI:76924)
hydroxysafflor yellow A (CHEBI:139030) has role platelet aggregation inhibitor (CHEBI:50427)
hydroxysafflor yellow A (CHEBI:139030) has role radical scavenger (CHEBI:48578)
hydroxysafflor yellow A (CHEBI:139030) is a C-glycosyl compound (CHEBI:20857)
hydroxysafflor yellow A (CHEBI:139030) is a enol (CHEBI:33823)
hydroxysafflor yellow A (CHEBI:139030) is a enone (CHEBI:51689)
hydroxysafflor yellow A (CHEBI:139030) is a phenols (CHEBI:33853)
Synonyms Sources
2,4-di-β-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl-1-oxo-2-propen-1-yl)]-2,5-cyclohexadien-1-one ChEBI
2,4-di-β-D-glucopyranosyl-3,4,5-trihydroxy-6-[(2E)-3-(4-hydroxyphenyl-1-oxo-prop-2-en-1-yl)]cyclohexa-2,5-dien-1-one ChEBI
HSYA ChEBI
safflomin A ChemIDplus
Manual Xrefs Databases
FDB020474 FooDB
HMDB0040677 HMDB
View more database links
Registry Numbers Types Sources
78281-02-4 CAS Registry Number ChemIDplus
8669627 Reaxys Registry Number Reaxys
Citations Waiting for Citations Types Sources
25626885 PubMed citation Europe PMC
26607471 PubMed citation Europe PMC
26754542 PubMed citation Europe PMC
26777519 PubMed citation Europe PMC
27063983 PubMed citation Europe PMC
27086971 PubMed citation Europe PMC
27176815 PubMed citation Europe PMC
27457091 PubMed citation Europe PMC
27599591 PubMed citation Europe PMC
27713966 PubMed citation Europe PMC
27731393 PubMed citation Europe PMC
27894114 PubMed citation Europe PMC
27909717 PubMed citation Europe PMC
28068632 PubMed citation Europe PMC
28074914 PubMed citation Europe PMC
28097465 PubMed citation Europe PMC
28122306 PubMed citation Europe PMC
28154251 PubMed citation Europe PMC
28191279 PubMed citation Europe PMC
28264629 PubMed citation Europe PMC
28468657 PubMed citation Europe PMC
28553231 PubMed citation Europe PMC
28840700 PubMed citation Europe PMC
28932195 PubMed citation Europe PMC
28966242 PubMed citation Europe PMC
29076598 PubMed citation Europe PMC
29107614 PubMed citation Europe PMC
29107696 PubMed citation Europe PMC
Last Modified
15 November 2017